Expansion▲ Bullish for Biocon

Biocon Malaysia facility wins UK approval for Semglee fill-finish operations

2 sources · first seen 10:11 25 Sept · updated 15:21 25 Sept

The brief

Written from 2 reports · check the source before you trade

UK MHRA approval covers Biocon’s Malaysia-based insulin fill-finish line for Semglee
The approval supports Biocon’s biosimilar manufacturing and international supply capabilities

the session the news first traded, and since

Stock	Traded	That day	vs Nifty	Volume	Since
BIOCON	Fri, 25 Sept	−1.3%	−1.6%	0.8×	−1.3% · Nifty +0.3%

✗ Classifier read this as positive; BIOCON fell 1.6% against the Nifty on the day it traded.

Pick a tag to see all its stories

2 reports · earliest 10:11